Takeda issues letter to the community regarding BAXJECT® II reconstitution devices
Update:
Please note we will have further updates for the community on Monday, August 28th.
Takeda has brought to our…
FOR IMMEDIATE RELEASE MEDIA CONTACT Ilana Ostrin Senior Director of Public Relations and Communications …
Payer Matrix
1400 N. Providence Road Building 2, Suite 5000
Media, PA 19063
customerservice@payermatrix.com
Via Electronic Email
Re: Payer Matrix identifying itself as both a ‘Patient Advocacy Company’ and a ‘…
Are you ready to make a real difference? Join the National Bleeding Disorders Foundation (NBDF) on a transformative journey as we seek a visionary CEO to lead our impactful mission. About NBDFNBDF has been at the forefront of…
From NHF to NBDF: A Time for Change
Speaker: Foundation Staff and Merz Branding
At the 2023 Bleeding Disorders Conference, the foundation announced its rebranding to the National Bleeding Disorders Foundation to create…
HEMGENIX (etranacogene dezapavovec-drlb) Patient Eligibility and Treatment Steps
Speaker: Dr. Richard Lemons
Learn how patients can qualify for HEMGENIX and how it works. Special thanks to CSL Behring for their generous support…
Revisions: 279Preamble MASAC is aware of multiple reports of persons with bleeding disorders being denied access to residential mental health and/or substance use disorder treatment facilities, despite being appropriate for…
Burden on parents of children with moderate or severe von Willebrand disease: The impact of clinical data
Speakers: Anna Olsson and Linda Myrin Westesson
NBDF's Wednesday Webinars are a free education series open to…
Federal Update on Telehealth Policy
Speaker: Kyle Zebley, American Telemedicine Association
NBDF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the…